Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
Nathalie A. Johnson(Genomics (United Kingdom)), Douglas E. Horsman(Genomics (United Kingdom))
Cited by 582
Related Papers
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
|Journal of Clinical Oncology|2012|971
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
|Blood|2013|396
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
|Blood Advances|2020|120